Adocia SA (EPA:ADOC)
5.04
+0.07 (1.31%)
May 14, 2026, 5:35 PM CET
Adocia Market Cap
Adocia has a market cap or net worth of €97.38 million as of May 14, 2026. Its market cap has increased by 31.30% in one year.
Market Cap
97.38M
Enterprise Value
100.75M
Revenue
3.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.04
Market Cap Chart
Since February 20, 2012, Adocia's market cap has increased from 93.74M to 97.38M, an increase of 3.88%. That is a compound annual growth rate of 0.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 97.38M | -25.67% |
| Dec 31, 2025 | 131.01M | 40.99% |
| Dec 31, 2024 | 92.92M | -42.69% |
| Dec 29, 2023 | 162.13M | 379.37% |
| Dec 30, 2022 | 33.82M | -41.93% |
| Dec 31, 2021 | 58.24M | 1.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 249.28M |
| Sensorion | 229.31M |
| Transgene | 215.55M |
| MaaT Pharma | 137.37M |
| ABIONYX Pharma | 128.76M |
| Innate Pharma | 117.29M |
| OSE Immunotherapeutics | 97.08M |
| Valerio Therapeutics Société anonyme | 84.01M |